Ukraine partners with Israel to deploy placenta-based radiation treatment in case of nuclear event
Israeli biotech firm Pluri has partnered with Ukraine to supply an innovative placenta-derived cell therapy as an emergency treatment for radiation sickness, aiming to bolster preparedness in the event of a nuclear attack or accident.